Nurix Therapeutics (NRIX) EBIT Margin (2019 - 2026)
Nurix Therapeutics (NRIX) posted EBIT Margin of -1041.73% for fiscal Q2 2026 (quarter ended May 31, 2026), down 932.05 percentage points from -109.68% a year earlier but up 437.71 percentage points from the prior quarter.
Nurix Therapeutics (NRIX) EBIT Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through May 31, 2026, EBIT Margin at Nurix Therapeutics was -982.37%, down 721.62 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it was -340.16%, up 50.36 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +24.50 percentage points (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' EBIT Margin was -390.52% in FY2024 (-189.11 pp), -201.41% in FY2023 (+274.59 pp), -476.01% in FY2022 (-79.75 pp) and -396.26% in FY2021 (-31.59 pp).
- Quarterly EBIT Margin has run from a low of -1479.45% in fiscal Q1 2026 to a high of -87.25% in fiscal Q2 2023 over five years.
- On a year-over-year basis, EBIT Margin has declined in each of the last four quarters, with an average year-over-year change of -387.63 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was fiscal Q4 2023, with a gain of 418.77 percentage points; the weakest was fiscal Q1 2026, with a drop of 1138.78 percentage points.
- According to Business Quant data, EBIT Margin for the three prior fiscal quarters was -1479.45% (Q1 2026), -612.03% (Q4 2025) and -1157.65% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Nurix Therapeutics | 2.45 Bn | 448.58 Mn | - | -1,041.73% |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -1,041.73% |
| Feb 28, 2026 | -1,479.45% |
| Nov 30, 2025 | -612.03% |
| Aug 31, 2025 | -1,157.65% |
| May 31, 2025 | -109.68% |
| Feb 28, 2025 | -340.67% |
| Nov 30, 2024 | -486.73% |
| Aug 31, 2024 | -433.83% |
| May 31, 2024 | -401.42% |
| Feb 29, 2024 | -272.65% |
| Nov 30, 2023 | -299.06% |
| Aug 31, 2023 | -216.67% |
| May 31, 2023 | -87.25% |
| Feb 28, 2023 | -338.60% |
| Nov 30, 2022 | -717.82% |
| Aug 31, 2022 | -432.93% |
| May 31, 2022 | -399.89% |
| Feb 28, 2022 | -444.28% |
| Nov 30, 2021 | -513.16% |
| Aug 31, 2021 | -282.84% |
Nurix Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();